Back
Axsome Therapeutics Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
AXSM
Axsome Therapeutics
Last Price:
$98.47
Seasonality Move:
27.21%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
Axsome Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 113.03 | Sell |
20-day SMA: | 119.39 | Sell |
50-day SMA: | 119.19 | Sell |
200-day SMA: | 96.19 | Buy |
8-day EMA: | 111.28 | Sell |
20-day EMA: | 117.05 | Sell |
50-day EMA: | 115.65 | Sell |
200-day EMA: | 99.45 | Sell |
Axsome Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.53 | Sell |
Relative Strength Index (14 RSI): | 25.19 | Sell |
Chaikin Money Flow: | -974698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.7 - 127.72) | Sell |
Bollinger Bands (100): | (90.29 - 121.45) | Sell |
Axsome Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Axsome Therapeutics Stock
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 98.86 while AXSM 8-day simple moving average is 113.03, which is a Sell signal.
-
The stock price of AXSM is 98.86 while Axsome Therapeutics 20-day SMA is 119.39, which makes it a Sell.
-
Axsome Therapeutics 50-day simple moving average is 119.19 while AXSM share price is 98.86, making it a Sell technically.
-
AXSM stock price is 98.86 and Axsome Therapeutics 200-day simple moving average is 96.19, creating a Buy signal.
AXSM Technical Analysis vs Fundamental Analysis
Sell
26
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy or a Sell?
-
Axsome Therapeutics stock is rated a SellThe current Axsome Therapeutics [AXSM] share price is $98.86. The Score for AXSM is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Axsome Therapeutics Stock Info
Market Cap:
4.8B
Price in USD:
98.86
Share Volume:
990.7K
Axsome Therapeutics 52-Week Range
52-Week High:
139.13
52-Week Low:
64.11
Sell
26
Axsome Therapeutics (AXSM)
is a Sell
Axsome Therapeutics Share Price Forecast
-
What is the Axsome Therapeutics stock price today?The Axsome Therapeutics stock price is 98.86 USD today.
-
Will AXSM stock go up or go down?Axsome Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Axsome Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Axsome Therapeutics is overvalued.
Is Axsome Therapeutics Stock a Buy?
-
Axsome Therapeutics share price is 98.86 while AXSM 8-day exponential moving average is 111.28, which is a Sell signal.
-
The stock price of AXSM is 98.86 while Axsome Therapeutics 20-day EMA is 117.05, which makes it a Sell.
-
Axsome Therapeutics 50-day exponential moving average is 115.65 while AXSM share price is 98.86, making it a Sell technically.
-
AXSM stock price is 98.86 and Axsome Therapeutics 200-day simple moving average is 99.45, creating a Sell signal.
Fundamental Analysis of Axsome Therapeutics
Is Axsome Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.34 per share, an increase this year of $1.79 per share, and an increase next year of $4.87 per share.
Technical Analysis of Axsome Therapeutics
Should I short Axsome Therapeutics stock?
-
AXSM Moving Average Covergence Divergence (MACD) indicator is -3.53, suggesting Axsome Therapeutics is a Sell
-
Axsome Therapeutics Relative Strength Index (RSI) is 25.19, which suggest Axsome Therapeutics is oversold
-
The Bollinger Bands (25) for Axsome Therapeutics is (113.7 - 127.72), which suggest Axsome Therapeutics is a Sell
-
The Bollinger Bands (100) for Axsome Therapeutics is (90.29 - 121.45), which suggest Axsome Therapeutics is a Sell
* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.